Tara Major
Family · Philadelphia, PANPI 1659678464
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.5% of the total across 280 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 21.9% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 280 payments — averaging $22.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$1K
- Lilly USA, LLC$690
- Boehringer Ingelheim$581
- AbbVie$447
- Novo Nordisk$426
- Teva Pharmaceuticals USA, Inc.$411
- plus $2K from 18 others
What the payments were for
- Food & beverage$6,10198%
- Education$952%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 59 | $1,356 |
| Lilly USA, LLC | 33 | $690 |
| Boehringer Ingelheim | 28 | $581 |
| AbbVie | 18 | $447 |
| Novo Nordisk | 25 | $426 |
| Teva Pharmaceuticals USA, Inc. | 19 | $411 |
| AstraZeneca | 17 | $366 |
| Abbott | 16 | $359 |
| Merck | 14 | $333 |
| Johnson & Johnson | 8 | $245 |
| Amgen | 9 | $156 |
| Bayer | 6 | $130 |
| Sanofi | 1 | $119 |
| Novartis | 6 | $100 |
| Exact Sciences | 4 | $92 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $70 |
| Astellas Pharma US Inc | 3 | $63 |
| Indivior Inc. | 1 | $61 |
| Phathom Pharmaceuticals, Inc. | 2 | $43 |
| Biogen | 2 | $40 |
| Sanofi-aventis U.S. LLC | 1 | $31 |
| Pfizer | 2 | $31 |
| Smith+Nephew | 1 | $30 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,196 in reported general payments places this provider in the 95th percentile of 4,717 family providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 80 | $53,695 |
| JardianceEmpagliflozin | 34 | $39,715 |
| TrulicityDulaglutide | 40 | $35,911 |
| OzempicSemaglutide | 26 | $32,038 |
| EliquisApixaban | 18 | $18,553 |
| FarxigaDapagliflozin Propanediol | 26 | $17,949 |
| Bydureon BciseExenatide Microspheres | 11 | $16,834 |
| Spiriva RespimatTiotropium Bromide | 18 | $10,270 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 278 | $9,736 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 65 | $9,646 |
| Spiriva HandihalerTiotropium Bromide | 11 | $5,985 |
| Breo ElliptaFluticasone/Vilanterol | 15 | $5,783 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 53 | $4,813 |
| Atorvastatin Calcium | 320 | $3,452 |
| Lidocaine | 95 | $3,305 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta | $1,356 | $59,47895 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $581 | $49,98552 claims |
| Lilly USA, LLCTrulicity | $690 | $35,91140 claims |
| Novo NordiskOzempic | $426 | $32,03826 claims |
| PfizerEliquis | $31 | $18,55318 claims |
| AstraZenecaFarxiga | $366 | $17,94926 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,717 family providers in Pennsylvania.
Other family in Philadelphia
- Bethany ThomasPhiladelphia$126K
- Anne CalvaresiPhiladelphia$81K
- Bethany MooneyPhiladelphia$73K
- Susan Estrella-EadesPhiladelphia$61K
- Michelle Vega-OlivoPhiladelphia$55K
- Danielle LandPhiladelphia$48K
- Nicole SmithPhiladelphia$37K
- Dana SerafinPhiladelphia$31K
- Tammaris KaschakPhiladelphia$27K
- Laura NoltePhiladelphia$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.